Analgesics - Ethiopia

  • Ethiopia
  • In Ethiopia, the revenue generated in the Analgesics market is projected to reach US$105.70m in 2024.
  • It is anticipated that the market will experience an annual growth rate of 12.40% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in this market, amounting to US$7,243.00m in 2024.
  • In terms of per person revenues, in Ethiopia generates US$0.82 in 2024.
  • Ethiopia is experiencing a growing demand for analgesics in the OTC Pharmaceuticals market, driven by increasing awareness of self-care and access to healthcare products.

Key regions: Canada, United States, United Kingdom, Australia, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics market in Ethiopia has experienced significant growth in recent years, driven by a combination of factors including changing customer preferences, emerging trends in the market, and local special circumstances. Customer preferences in the Analgesics market in Ethiopia have shifted towards a preference for over-the-counter (OTC) pain relief medications. This can be attributed to several reasons, including the convenience and accessibility of OTC medications, as well as a growing awareness among consumers about the importance of self-care and managing minor ailments without the need for prescription medications. Additionally, the affordability of OTC analgesics compared to prescription drugs has also contributed to the increasing demand for these products.Trends in the Analgesics market in Ethiopia indicate a growing demand for natural and herbal pain relief remedies. This trend is in line with the global shift towards natural and alternative healthcare solutions. Consumers are increasingly seeking out products that are perceived as more natural and have fewer side effects. As a result, there has been a rise in the availability and popularity of herbal analgesics in the market.Local special circumstances in Ethiopia have also played a role in the development of the Analgesics market. The country has a large population with a high prevalence of certain health conditions, such as musculoskeletal disorders and headaches, which contribute to the demand for pain relief medications. Additionally, the increasing urbanization and changing lifestyles in Ethiopia have led to a rise in the incidence of stress-related ailments, further driving the demand for analgesics.Underlying macroeconomic factors have also influenced the growth of the Analgesics market in Ethiopia. The country has experienced steady economic growth in recent years, leading to an increase in disposable income and improving standards of living. This has resulted in a higher spending power among consumers, allowing them to afford healthcare products, including analgesics. Furthermore, the government's efforts to improve healthcare infrastructure and increase access to healthcare services have also contributed to the growth of the market.In conclusion, the Analgesics market in Ethiopia has witnessed significant growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards OTC medications, the demand for natural and herbal remedies, the prevalence of certain health conditions, and the country's economic growth have all contributed to the development of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)